Parameter | Score |
---|---|
1. Scale | A |
2. Study Population | A |
3. Samples | A |
4. Measurand | A |
5. Pre-Analytical | A |
6. Replicate Analysis | B |
7. Steady State | B |
8. Outlier Analysis | C |
9. Normality | B |
10. Variance Homogeneity | C |
11. ANOVA | B |
12. CI | A |
13. No of Results | C |
14. Concentrations | A |
15. Total Score | C8,10,13 |
Comment |
Parameter | Score |
---|---|
Matrix | Serum |
Measurand | Cystatin C |
Unit | mg / L |
Overall Analytical Principle Method | Nephelometry |
Number of Subjects | 10 |
Number of Subjects included in BV estimation | 10 |
Ethinicity | Caucasian |
Age Mean / Median | |
Age Min | 19.0 |
Age Max | 27.0 |
Age SD | |
Number of Males | 4 |
Number of Females | 6 |
State of Well Being |
Healthy (excl pregnant)
|
Diseases | |
Study Duration Length | 42 |
Study Duration Units | Day |
Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
Interval Units | Week |
Sampling Times | Start Time:
12:30
End Time: 14:30 |
Number of Samples | 6 |
Average Number of Samples Used for BV Estimation | 6.0 |
Average Number of Replicates | 2.0 |
Estimates of CVi | 4.5 |
Calculated Confidence Intervals of CVi | Lower: 3.62, Upper: 5.75 |
Estimates of CVg | 13.0 |
Calculated Confidence Intervals of CVg | Lower: 8.97, Upper: 22.99 |
Analytical CV | 2.5 |
Calculated Confidence Intervals of Analytical CV | Lower: 2.12, Upper: 3.04 |
Measurand Mean | 0.77 |
Measurand Min | |
Measurand Max | |
Measurand SD |